Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 May;47(5):1091-1100.
doi: 10.1007/s40618-023-02220-2. Epub 2023 Oct 27.

Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people

D Santi  1   2   3 , G Spaggiari  4   5 , L Marinelli  6 , M Cacciani  4   7 , S Scipio  7 , A Bichiri  6 , A Profeta  6 , A R M Granata  4   5 , M Simoni  4   7   5 , F Lanfranco  8 , C Manieri  6 , E Ghigo  6 , G Motta  6
Affiliations
Observational Study

Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people

D Santi et al. J Endocrinol Invest. 2024 May.

Abstract

Purpose: Gender-affirming hormone treatment (GAHT) is one of the main demands of transgender and gender diverse (TGD) people, who are usually categorised as transgender assigned-male-at birth (AMAB) and assigned-female-at birth (AFAB). The aim of the study is to investigate the long-term therapeutic management of GAHT, considering hormonal targets, treatment adjustments and GAHT safety.

Methods: A retrospective, longitudinal, observational, multicentre clinical study was carried out. Transgender people, both AMAB and AFAB, were recruited from two Endocrinology Units in Italy (Turin and Modena) between 2005 and 2022. Each subject was managed with specific and personalized follow-up depending on the clinical practice of the Centre. All clinical data routinely collected were extracted, including anthropometric and biochemical parameters, lifestyle habits, GAHT regime, and cardiovascular events.

Results: Three-hundred and two transgender AFAB and 453 transgender AMAB were included. Similar follow-up duration (p = 0.974) and visits' number (p = 0.384) were detected between groups. The transgender AFAB group reached therapeutic goals in less time (p = 0.002), fewer visits (p = 0.006) and fewer adjustments of GAHT scheme (p = 0.024). Accordingly, transgender AFAB showed a higher adherence to medical prescriptions compared to transgender AMAB people (p < 0.001). No significantly increased rate of cardiovascular events was detected in both groups.

Conclusion: Our real-world clinical study shows that transgender AFAB achieve hormone target earlier and more frequently in comparison to transgender AMAB individuals. Therefore, transgender AMAB people may require more frequent check-ups in order to tailor feminizing GAHT and increase therapeutic adherence.

Keywords: AFAB; AMAB; Gender affirming hormonal therapy; Transgender and gender diverse people; Transgender assigned female at birth; Transgender assigned male at birth.

PubMed Disclaimer

References

    1. Fisher AD et al (2022) SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people, (in eng). J Endocrinol Invest 45(3):657–673. https://doi.org/10.1007/s40618-021-01694-2 - DOI - PubMed
    1. Meyer-Bahlburg HF (2010) From mental disorder to iatrogenic hypogonadism: dilemmas in conceptualizing gender identity variants as psychiatric conditions, (in eng). Arch Sex Behav 39(2):461–476. https://doi.org/10.1007/s10508-009-9532-4 - DOI - PubMed - PMC
    1. Coleman E et al (2022) Standards of care for the health of transgender and gender diverse people, version 8, (in eng). Int J Transgend Health 23(Suppl 1):S1-s259. https://doi.org/10.1080/26895269.2022.2100644 - DOI - PubMed - PMC
    1. Goodman M, Adams N, Corneil T, Kreukels B, Motmans J, Coleman E (2019) Size and distribution of transgender and gender nonconforming populations: a narrative review, (in eng). Endocrinol Metab Clin North Am 48(2):303–321. https://doi.org/10.1016/j.ecl.2019.01.001 - DOI - PubMed
    1. Winter S et al (2016) Transgender people: health at the margins of society, (in eng). Lancet (London, England) 388(10042):390–400. https://doi.org/10.1016/s0140-6736(16)00683-8 - DOI - PubMed

Publication types

LinkOut - more resources